Mebias Discovery

3675 Market St Ste 200
Philadelphia, PA 19104

Mebias Discovery is a Philadelphia-based company specializing in innovative drug discovery and development, with a focus on G Protein Coupled Receptors (GPCRs). Their proprietary membrane protein-NMR drug discovery platform enables the identification of highly selective molecules that bind to GPCR targets, eliminating adverse effects and maximizing therapeutic potential.

With seven years of experience, Mebias Discovery has successfully validated their unique drug discovery platform and identified an FDA-approved Investigational New Drug for the mu-opioid receptor. Additionally, they are currently developing Sphingosine 1-phosphate receptor agonists for the treatment of neuropathic pain.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesPennsylvaniaPhiladelphiaMebias Discovery

Partial Data by Infogroup (c) 2025. All rights reserved.